{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:57:19Z","timestamp":1790715439624,"version":"4.1.0"},"reference-count":39,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To characterize attitudes and perceptions regarding risks and benefits of cannabis before Canadian legalization for recreational use, both in general and between cannabis users and nonusers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional sample of community adults assessed in the month before legalization (September 17 to October 17, 2018). Overall, 1,480 individuals (60% female) of an average age of 34.5 years (\u00b113.92) were included in the analysis; 48% reported cannabis use in the past 6 months. Attitudes and perceptions were assessed using a subset of items from the Canadian Cannabis Survey, the National Survey on Drug Use and Health, and the Risks and Benefits of Cannabis Use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most commonly identified risks of cannabis were impaired memory (67%) and legal problems (54%). Most also identified addiction as a risk (52%), although 25% reported that cannabis was not addictive. The most commonly identified benefits were for pain relief (94%) and management of stress, anxiety, or depression (80%). Active cannabis users systematically reported lower endorsement of risks and higher endorsement of benefits. Only 6% of respondents anticipated increasing cannabis use postlegalization. Among other legal substances, medical cannabis was considered the most socially acceptable, followed by alcohol, recreational cannabis, electronic cigarettes, and then combustible cigarettes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Before legalization, attitudes toward cannabis in this sample of Canadian adults were generally favorable, particularly for medical cannabis. Perceptions of risk were often compatible with existing evidence, but notable proportions underendorsed risk of cannabis use disorder and overendorsed benefits for mental health. These results suggest priorities for public health messaging and provide benchmarks for understanding attitudinal changes postlegalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2019.0088","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T22:20:30Z","timestamp":1591136430000},"page":"526-536","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["Attitudes and Beliefs Toward Cannabis Before Recreational Legalization: A Cross-Sectional Study of Community Adults in Ontario"],"prefix":"10.1177","volume":"7","author":[{"given":"Jasmine","family":"Turna","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."},{"name":"Department of Psychiatry and Behavioural Neurosciences, Peter Boris Centre for Addictions Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Balodis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."},{"name":"Department of Psychiatry and Behavioural Neurosciences, Peter Boris Centre for Addictions Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Van Ameringen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."},{"name":"Department of Psychiatry and Behavioural Neurosciences, MacAnxiety Research Centre, McMaster University, Hamilton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Busse","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."},{"name":"Department of Anesthesia, McMaster University, Hamilton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacKillop","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."},{"name":"Department of Psychiatry and Behavioural Neurosciences, Peter Boris Centre for Addictions Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"e_1_3_4_2_2","first-page":"10","article-title":"Analysis of trends in the prevalence of cannabis use in Canada","volume":"29","author":"Rotermann M","year":"2018","unstructured":"Rotermann M, , Macdonald R. Analysis of trends in the prevalence of cannabis use in Canada. Health Rep. 2018; 29:10\u201320.","journal-title":"Health Rep"},{"key":"e_1_3_4_3_2","unstructured":"Health Canada. Understanding the new access to cannabis for medical purposes regulations\u2014Canada.ca. 2016 (cited March 3 2019). www.canada.ca\/en\/health-canada\/services\/publications\/drugs-health-products\/understanding-new-access-to-cannabis-for-medical-purposes-regulations.html (last accessed August28 2019)."},{"key":"e_1_3_4_4_2","unstructured":"Health Canada. Cannabis for medical purposes under the Cannabis Act: information and improvements\u2014Canada.ca. 2018 (cited March 3 2019). www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/medical-use-cannabis.html (last accessed August28 2019)."},{"key":"e_1_3_4_5_2","first-page":"1","article-title":"Monitoring the future national results on adolescent drug use: overview of key findings","author":"Johnston LD","year":"2014","unstructured":"Johnston LD, , O'Malley PM, , Miech RA, et al. Monitoring the future national results on adolescent drug use: overview of key findings. Institute for Social Research, The University of Michigan: Ann Arbor, MI,, 2014; 1\u20137.","journal-title":"Institute for Social Research, The University of Michigan: Ann Arbor, MI,"},{"key":"e_1_3_4_6_2","unstructured":"Johnston LD O'Malley PM Bachman JG et al. Monitoring the future national survey results on drug use 1975\u20132014: Volume 2 college students and adults ages 19\u201355. University of Michigan: Ann Arbor MI 2015."},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30208-5"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13523"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0810"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402309"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_4_12_2","unstructured":"Health Canada. Canadian cannabis survey 2018 summary. 2018 (cited February 27 2019). www.canada.ca\/en\/services\/health\/publications\/drugs-health-products\/canadian-cannabis-survey-2018-summary.html (last accessed August28 2019)."},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","unstructured":"Forsyth CJ Copes H. National survey of drug use and health. In: Encyclopedia of social deviance. Newbury Park CA: SAGE Publications 2014.","DOI":"10.4135\/9781483340470"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.02.017"},{"key":"e_1_3_4_15_2","first-page":"791","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II","volume":"88","author":"Babor TF","year":"2006","unstructured":"Babor TF, , Aasland OG, , Grant M, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 2006; 88:791\u2013804.","journal-title":"Addiction"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"e_1_3_4_17_2","unstructured":"IBM. IBM SPSS statistics 25. IBM. 2017."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-017-0189-z"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.194381"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13347"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.08.036"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-018-0148-0"},{"key":"e_1_3_4_23_2","first-page":"17","article-title":"Marijuana use and perceptions of risk and harm: a survey among Canadians in 2016","volume":"13","author":"Spackman E","year":"2017","unstructured":"Spackman E, , Haines-Saah R, , Danthurebandara VM, et al. Marijuana use and perceptions of risk and harm: a survey among Canadians in 2016. Healthc Policy. 2017; 13:17\u201327.","journal-title":"Healthc Policy"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0027622"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15070907"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.22664"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2016.03.005"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.3229"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.4500"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001293"},{"key":"e_1_3_4_31_2","first-page":"CD012182","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke M","year":"2018","unstructured":"M\u00fccke M, , Phillips T, , Radbruch L, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018; 3:CD012182.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_32_2","unstructured":"National Academies of Sciences Engineering Medicine. Committee on the Health Effects of Marijuana: an evidence review and Research Agenda Board on Population Health and Public Health Practice Health and Medicine Division. A Report of Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations for Research. 2017;440. www.national-academies.org (last accessed August28 2019)."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6358"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.02.009"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2015.1004581"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/CXA.0000000000000059"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2016.0010"},{"key":"e_1_3_4_38_2","unstructured":"The Daily\u2014National Cannabis Survey third quarter. 2019 (cited February 11 2020). www150.statcan.gc.ca\/n1\/daily-quotidien\/191030\/dq191030a-eng.htm?HPA=1 (last accessed August28 2019)."},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","unstructured":"Carliner H Brown QL Sarvet AL et al. Cannabis use attitudes and legal status in the U.S.: a review. Prev Med. 2017; 104:13\u201323.","DOI":"10.1016\/j.ypmed.2017.07.008"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/1178221818815491"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2019.0088","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2019.0088","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2019.0088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:20Z","timestamp":1777385480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2019.0088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8,1]]}},"alternative-id":["10.1089\/can.2019.0088"],"URL":"https:\/\/doi.org\/10.1089\/can.2019.0088","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}